In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy

被引：0
|
作者：
Tanya Lynn Applegate
Donald John Birkett
Glen John Mcintyre
Angel Belisario Jaramillo
Geoff Symonds
John Michael Murray
机构：
[1] Johnson and Johnson Research Pty Ltd,The National Centre in HIV Epidemiology and Clinical Research
[2] Level 4 Biomedical Building,School of Molecular and Microbial Biosciences, School of Biological Sciences
[3] University of New South Wales,School of Mathematics and Statistics
[4] University of Sydney,undefined
[5] Cell and Molecular Therapies,undefined
[6] Faculty of Medicine,undefined
[7] University of New South Wales,undefined
来源：
Retrovirology | / 7卷
关键词：
Gene Therapy; Infected Cell; Chronic Granulomatous Disease; Resistant Virus; Uninfected Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy
    Applegate, Tanya Lynn
    Birkett, Donald John
    Mcintyre, Glen John
    Jaramillo, Angel Belisario
    Symonds, Geoff
    Murray, John Michael
    RETROVIROLOGY, 2010, 7
  • [2] HIV-1 genetic subtypes and antiretroviral therapy resistance testing
    Galpin, S
    Beddows, S
    Johargy, A
    Ashraf, A
    Prater, AJ
    White, N
    Clarke, J
    McClure, M
    Weber, JN
    AIDS, 2000, 14 : S118 - S118
  • [3] Standard vaccines increase HIV-1 transcription during antiretroviral therapy
    Yek, Christina
    Gianella, Sara
    Plana, Montserrat
    Castro, Pedro
    Scheffler, Konrad
    Garcia, Felipe
    Massanella, Marta
    Smith, Davey M.
    AIDS, 2016, 30 (15) : 2289 - 2298
  • [4] HIV-1, antiretroviral therapy, and malaria
    Rogerson, S
    LANCET, 2003, 362 (9389): : 1008 - 1009
  • [5] HIV-1 Antiretroviral Drug Therapy
    Arts, Eric J.
    Hazuda, Daria J.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (04):
  • [6] Antiretroviral therapy targeting HIV-1 viral infectivity factor; in silico approach
    Karau, Muriira G.
    Karau, Bundi P.
    RETROVIROLOGY, 2009, 6
  • [7] Antiretroviral therapy targeting HIV-1 viral infectivity factor; in silico approach
    Muriira G Karau
    Bundi P Karau
    Retrovirology, 6
  • [8] HIV-1 Subtypes and Primary Antiretroviral Resistance Mutations in Antiretroviral Therapy Naive HIV-1 Infected Individuals in Turkey
    Sayan, M.
    Willke, A.
    Ozgunes, N.
    Sargin, F.
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (04) : 306 - 311
  • [9] ZIDOVUDINE RESISTANCE AND HIV-1 DISEASE PROGRESSION DURING ANTIRETROVIRAL THERAPY
    DAQUILA, RT
    JOHNSON, VA
    WELLES, SL
    JAPOUR, AJ
    KURITZKES, DR
    DEGRUTTOLA, V
    REICHELDERFER, PS
    COOMBS, RW
    CRUMPACKER, CS
    KAHN, JO
    RICHMAN, DD
    ANNALS OF INTERNAL MEDICINE, 1995, 122 (06) : 401 - 408
  • [10] Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya
    Steegen K.
    Luchters S.
    Dauwe K.
    Reynaerts J.
    Mandaliya K.
    Jaoko W.
    Plum J.
    Temmerman M.
    Verhofstede C.
    AIDS Research and Therapy, 6 (1)
12345